News
No new patients should take Lilly's cancer drug Lartruvo, sa...
Regulators on both sides of the Atlantic have ruled that no new patients should start treatment with Eli Lilly’s Lartruvo (olaratumab) for soft tissue sarcoma, after a study that was suppos
